SMAD2 and thoracic aortic aneurysm: Modification of the histone H3 marker near the promoter of the SMAD2 gene has been observed in patients with BAV-associated thoracic aortic aneurysm as an epigenetic mechanism behind SMAD2 overexpression [62].